ESC/ERS PAH Four-Strata Risk Assessment

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۱۰۰۰ • واحد: m

حداقل ۱ — حداکثر ۵۰۰۰۰ • واحد: ng/L

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
risk stratum
—stratum
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • stratified≥ 0
Direct Clinical Answer

The ESC/ERS PAH Four-Strata Risk Assessment calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include who fc. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Pulmonary arterial hypertension 4-strata risk (ESC/ERS 2022).

Clinical Indication

The ESC/ERS PAH Four-Strata Risk Assessment is indicated for bedside clinical practice to support Pulmonary arterial hypertension 4-strata risk (ESC/ERS 2022).. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.

Limitations & Contraindications

In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.

Clinical Pearls & Action Plan

Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines.

Formula & Variables:

Each variable scored 1-4; mean rounded to nearest stratum

Input Parameters

NameTypeRequiredDescription
six_mwdfloatYes6-minute walk distance(m)
peptide_valuefloatYesBNP or NT-proBNP value(ng/L)

Score Interpretation & Guidance

RangeStageDescription
≥ 0stratifiedRisk stratum

Evidence-Based References (EBM)

  • Humbert M, et al. 2022 ESC/ERS Guidelines for pulmonary hypertension. Eur Heart J. 2022;43(38):3618-3731.
  • Hoeper MM, et al. Mortality in pulmonary arterial hypertension: prediction by the 2022 ESC/ERS risk stratification. Eur Respir J. 2022.

Related calculators